Which of the following ICU sedation drug causes neuroleptic malignant syndrome:
## **Core Concept**
Neuroleptic malignant syndrome (NMS) is a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic medication. It is characterized by fever, muscle rigidity, autonomic dysfunction, and altered mental status. The condition requires immediate medical attention.
## **Why the Correct Answer is Right**
The correct answer, , is associated with causing neuroleptic malignant syndrome because it is a typical antipsychotic drug. Typical antipsychotics are known to block dopamine receptors in the brain, which can lead to NMS. This class of drugs includes haloperidol, which is commonly used in ICU settings for sedation and has a well-documented risk of inducing NMS.
## **Why Each Wrong Option is Incorrect**
* **Option A:** is incorrect because it is not commonly associated with NMS. It might be used in different contexts but is not a primary drug linked to this condition.
* **Option B:** is incorrect because, while it is used for sedation, it does not have a significant association with NMS.
* **Option C:** is incorrect because it is not typically used in ICU settings for sedation in a way that would be associated with NMS.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that when using antipsychotic drugs like haloperidol for sedation in ICU, monitoring for early signs of NMS is crucial. Early recognition includes identifying muscle rigidity, fever, and altered mental status. Discontinuing the offending agent promptly is critical.
## **Correct Answer:** .